About sourcinglink net - ONPH
Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
ONPH At a Glance
Oncology Pharma, Inc.
One Sansome Street
San Francisco, California 94104
| Phone | 1-415-869-1038 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Major | Net Income | -104,626,728.00 | |
| Sector | Health Technology | Employees | N/A | |
| Fiscal Year-end | 03 / 2023 | |||
| View SEC Filings |
ONPH Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 100.244 |
| Price to Cash Flow Ratio | 306.67 |
| Enterprise Value to EBITDA | -1,832.341 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.006 |
ONPH Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
ONPH Liquidity
| Current Ratio | 0.005 |
| Quick Ratio | 0.005 |
| Cash Ratio | 0.005 |
ONPH Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -8,471.395 |
| Return on Equity | -19,427.829 |
| Return on Total Capital | -5,480.201 |
| Return on Invested Capital | -19,427.829 |
ONPH Capital Structure
| Total Debt to Total Equity | 53.09 |
| Total Debt to Total Capital | 34.679 |
| Total Debt to Total Assets | 31.193 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |